Browse > Article
http://dx.doi.org/10.5012/bkcs.2005.26.12.1941

CoMFA and CoMSIA on the Inhibition of Calcineurin-NFAT Signaling by Blocking Protein-Protein Interaction with N-(4-Oxo-1(4H)-naphthalenylidene)benzenesulfonamide Derivatives  

Myung, Pyung-Keun (College of Pharmacy, Chungnam National University)
Park, Kyung-Yong (Research Center for Transgenic Cloned Pigs, Chungnam National University)
Sung, Nack-Do (Division of Applied Biology & Chemistry, Chungnam National University)
Publication Information
Abstract
To raises the possibility of designing effective inhibitors, 3D-QSAR for the inhibition of calcineurin-NFAT signaling by new N-(4-oxo-1(4H)-naphthalenylidene benzenesulfonamide derivatives as inhibitors of intracellular protein-protein interactions were studied using CoMFA and CoMSIA methodology. The three templates, N-(4-oxo-1(4H)-naphthalenylidene)benzenesulfonamide (A), benzenesulfonamide (B) and 4-oxo-1(4H)-naphthalenylidene (C) were selected to improve the statistic of the present 3D-QSAR models. The best models with combination of standard field in CoMFA, and steric field and electrostatic field in CoMSIA derived from the template, B and C, because most of the compounds tend not to be aligned in template A. From the based on the CoMFA and CoMSIA contour maps, the $R_1$ and $R_2$ groups on 4-oxo-1(4H) naphthalenylidene ring are steric favor. The ortho position on the benzenesulfonyl ring is steric disfavor and the meta position is steric favor. In addition, the oxygene atom of carbonyl group will have better inhibition activities as it has a negative charge favor. From these findings, we can conclude that the analyses of the contour maps provided insight into possible modification of molecules for effective inhibitiors.
Keywords
N-(4-Oxo-1(4H)-naphthalenylidene)benzenesulfonamides; Immunomodulatory agent; Calcineurin-NFAT signaling; CoMFA & CoMSIA model;
Citations & Related Records

Times Cited By Web Of Science : 4  (Related Records In Web of Science)
Times Cited By SCOPUS : 4
연도 인용수 순위
1 Aramburu, J.; Garcia-Cozar, F.; Raghavan, A.; Okamura, H.; Rao, A.; Hogan, P. G. Mol. Cell. 1998, 1, 627   DOI   ScienceOn
2 Aramburu, J.; Yaffe, M. B.; Lopez-Rodríguez, C.; Cantley, L. C.; Hogan, P. G.; Rao, A. Science 1999, 285, 2129   DOI   ScienceOn
3 Roehrl, M. H.; Kang, S.; Aramburu, J.; Wagner, G.; Rao, A.; Hogan, P. G. Proc. Natl. Acad. Sci. USA 2004, 101, 7544
4 Kubinyi, H., In 3D-QSAR in Drug Design; Theory, Methods and Applications; Escom: Leiden, 1993
5 Cramer, R. D.; Patterson, D. E.; Bunce, J. D. J. Am. Chem. Soc. 1988, 110, 5959   DOI   ScienceOn
6 Klebe, G. Prospect Drug Discovery Des. 1998, 12, 87   DOI   ScienceOn
7 Geladi, P. J. Chemon. 1998, 2, 231
8 Cramer, R. D., III.; Bunce, J. D.; Patterson, D. E. Quant. Struct. Act. Relat. 1988, 7, 18   DOI
9 Hansch, C.; Steward, A. R. J. Med. Chem. 1964, 7, 691   DOI
10 Fujita, T. In Progress in Physical Organic Chemistry; Taft, R., Ed.; Wiely & Sons: 1983; Vol. 14, pp 75-113
11 Shaw, K. T.; Ho, A. M.; Raghavan, A.; Kim, J.; Jain, J.; Park, J.; Sharma, S.; Rao, A.; Hogan, P. G. Proc. Natl. Acad. Sci., USA 1995, 92, 11205   DOI   ScienceOn
12 Thomson, A. W. In Therapeutic Immunosuppression; Kluwer Academic Publishers: 2001; p 130
13 Bohlin, L. Phytochem. Rev. 1995, 37, 137
14 Pawson, T.; Scott, J. D. Science 1997, 278, 2075   DOI   ScienceOn
15 Beals, C. R.; Clipstone, N. A.; Ho, S. N.; Crabtree, G. R. Genes. Dev. 1997, 11, 824   DOI   ScienceOn
16 Klebe, G.; Abraham, U. J. Comput. Aid. Mol. Des. 1999, 13, 1
17 Bohm, M.; Sturzebecher, J.; Klebe, G. J. Med. Chem. 1999, 42, 458   DOI   ScienceOn
18 Tripos Associates, Inc., 1699 S. Hanley Road, Suite 303, St. Louis, MO., 63144-2913 U.S.A., http://www.tripos.com/Bookshelf/qsar/
19 Kerr, R. Biophys. J. 1964, 67, 1501   DOI   ScienceOn
20 Purcell, W. P.; Singer, J. A. J. Chem. Eng. Data. 1967, 12, 235   DOI
21 Klebe, G. In 3D QSAR Drug Design, Theory, Methods and Applications: Structural Alignment of Molecules; Kubinyi, H., Ed.; ESCOM: Leiden, 1993; pp 173-199
22 Stahle, L.; Wold, S. Prog. Med. Chem. 1988, 25, 291   DOI
23 Marshall, G. R.; Barry, C. D.; Bosshard, H. E.; Dammkoehler, R. A.; Dunn, D. A. In Computer-Assisted Drug Design: The Conformational Parameter in Drug Design; Active Analog Approach; Olsen, E. C.; Christoffersen, R. E., Eds.; American Chemical Society: Washington, D. C. 1979; pp 205-226
24 Raichurkar, A. V.; Kulkarni, V. M. J. Med. Chem. 2003, 46, 4419   DOI   ScienceOn